Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
Acute, adipocyte, Akero, alive, alliance, ANOVA, antagonist, approva, ASC, Asher, AstraZeneca, ASU, Biden, bifurcation, BioNTech, biopsy, blocker, Bonferroni, broken, byAmgen, CAP, captured, CEE, CFB, closure, Codification, consequential, Daniel, Democratic, disappearance, dissipate, distinct, diverge, downsizing, drop, Dung, Eastern, ED, elastography, electoral, embedded, EP, EPS, Ewopharma, exit, FASB, feature, GAAP, globe, hardship, Harrison, Hepatology, HK, Holy, IDMC, immunotherapy, inhibitory, Intracoastal, IP, IRBl, Johnson, Joseph, jurisdiction, Kopin, longevity, matching, missed, Mitchell, Moderna, multiorgan, nanomolar, Nazareth, neutralized, nM, noninvasive, Novavax, OCA, Oxford, oxygen, Parameter, PCFB, Petach, Pinnacle, pneumonia, PPACA, Prof, PTO, pursuit, Radcliffe, radiographic, recived, Reconciliation, reconciling, recoup, Regeneron, regime, remdesivir, renegotiate, resource, resubmission, rich, SD, sector, Senate, shift, SNS, spectrum, SSC, stable, Stadler, Stephen, SUBSIDIARIY, susceptible, thirteen, threat, tied, tracing, undiscounted, unrecognized, unsatisfactory, vaccine, Veklury, Viking, Visiting, Vriew, workplace, younger
Removed:
abnormal, Allergan, Amending, andin, anemia, anin, ascertained, assaysin, assumption, autoimmunity, baricitninib, bone, cartilage, chemotherapeutic, choose, chronicity, commitment, comparability, compelling, computation, computed, consistently, corroborated, cured, cushioning, Dash, debtor, Derecognition, derecognized, DIC, diffuse, discovering, disposed, distinguish, dividing, earliest, embodying, estimating, evaporation, extinguished, eyefite, facilitate, fight, film, finalized, flexible, fluid, frame, fusion, ganglion, goodwill, guaranteed, guaranteeing, hearing, includein, inin, intragroup, irritation, JAK, kinase, leflunomide, legally, lowest, lymphoma, Meitav, membrane, migrate, minimizing, modifiable, mononuclear, neuropathy, nodular, ocular, optic, outflow, participant, pattern, peripheral, plaquenil, Plenum, postmenopausal, postponement, propose, prospectively, reading, relocation, researching, resultant, retina, retinal, rub, Sabby, Seikagaku, settle, sexual, spinoff, Steroidal, strategically, subPatent, sulfasalazine, swelling, symmetry, synovial, tear, terminating, tofacitinib, translating, Ultratrend, unadjusted, uniform, unrestricted, unused, verified, virtually, Visiongain, visual, Wainwright, warmth, wearing, Xeljanz
Filing tables
Filing exhibits
CANF similar filings
Filing view
External links
Exhibit 15.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the Registration Statement (Form S-8 No. 333-227753) pertaining to stock option plans and Registration Statements (Form F-3 No. 333-195124, 333-236064, 333-209037 and 333-249063), of Can-Fite Biopharma Ltd. and in the related Prospectus of our report dated March 25, 2021 with respect to the consolidated financial statements of Can-Fite Biopharma Ltd., included in this Annual Report (Form 20-F) for the year ended December 31, 2020.
/s/ Kost Forer Gabbay & Kasierer | |
Tel-Aviv, Israel | Kost Forer Gabbay & Kasierer |
March 25, 2021 | A Member of Ernst & Young Global |